We are live on ! Find out more
BG

Bahl & Gaynor Portfolio holdings

AUM $19.8B
1-Year Est. Return 19.53%
This Fund
S&P 500
This Quarter Est. Return
+1.96%
1 Year Est. Return
+19.53%
3 Year Est. Return
+63.97%
5 Year Est. Return
+84.2%
10 Year Est. Return
+296.44%
AUM
$6.24B
AUM Growth
+$139M
Cap. Flow
+$46.3M
Cap. Flow %
0.74%
Top 10 Hldgs %
26.92%
Holding
404
New
21
Increased
154
Reduced
178
Closed
12

Top Buys

Rank Stock Value
1
MMM icon
3M
MMM
+$83M
2
LYB icon
LyondellBasell Industries
LYB
+$52.1M
3
BAX icon
Baxter International
BAX
+$29.4M
4
ADI icon
Analog Devices
ADI
+$25.2M
5
DD
Du Pont De Nemours E I
DD
+$23.5M

Top Sells

Rank Stock Value
1
INTC icon
Intel
INTC
+$55.6M
2
OKE icon
Oneok
OKE
+$38.8M
3
BMY icon
Bristol-Myers Squibb
BMY
+$38.1M
4
MCD icon
McDonald's
MCD
+$33.4M
5
T icon
AT&T
T
+$30.5M

Sector Composition

Rank Sector Weight
1 Healthcare 16.35%
2 Technology 14.89%
3 Consumer Staples 14.37%
4 Industrials 12.52%
5 Energy 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MWIV
276
DELISTED
MWI VETERINARY SUPPLY, INC.
MWIV
$480K 0.01%
3,087
+127
+4% +$21.3K
POWI icon
277
Power Integrations
POWI
$3.29B
$479K 0.01%
14,572
+542
+4% +$16.4K
BNY
278
Bank of New York Mellon
BNY
$108B
$470K 0.01%
13,312
-200
-1% -$6.61K
TEVA icon
279
Teva Pharmaceuticals
TEVA
$40.6B
$462K 0.01%
8,754
-4,046
-32% -$187K
BRO icon
280
Brown & Brown
BRO
$23.8B
$448K 0.01%
29,110
+1,930
+7% +$29.6K
ACH
281
Accendra Health
ACH
$224M
$447K 0.01%
12,754
+1,120
+10% +$39.5K
HUB.A
282
DELISTED
HUBBELL INC CL-A
HUB.A
$445K 0.01%
4,000
– –
DRI icon
283
Darden Restaurants
DRI
$24.1B
$439K 0.01%
9,678
-4,609
-32% -$206K
CVS icon
284
CVS Health
CVS
$123B
$436K 0.01%
5,823
+484
+9% +$34.2K
RBA icon
285
RB Global
RBA
$17.2B
$433K 0.01%
17,929
+799
+5% +$18.3K
AFG icon
286
American Financial Group
AFG
$12.2B
$422K 0.01%
7,311
– –
K
287
DELISTED
Kellanova
K
$414K 0.01%
7,030
-9
-0.1% -$511
STAG icon
288
STAG Industrial
STAG
$7.1B
$413K 0.01%
17,120
+6,890
+67% +$154K
CMCSK
289
DELISTED
COMCAST CORP SPL A (NEW)
CMCSK
$404K 0.01%
8,287
-139
-2% -$6.78K
BLKB icon
290
Blackbaud
BLKB
$2.1B
$399K 0.01%
12,733
+533
+4% +$17.9K
NEOG icon
291
Neogen
NEOG
$2.46B
$398K 0.01%
23,605
-2,216
-9% -$36.2K
OCR
292
DELISTED
OMNICARE INC
OCR
$395K 0.01%
6,618
– –
THI
293
DELISTED
TIM HORTONS INC COM, CANADA
THI
$394K 0.01%
7,124
+294
+4% +$15.9K
LHX icon
294
L3Harris
LHX
$53.9B
$393K 0.01%
5,373
-250
-4% -$17.9K
TXT icon
295
Textron
TXT
$15.1B
$393K 0.01%
10,000
– –
IFF icon
296
International Flavors & Fragrances
IFF
$21.6B
$388K 0.01%
4,052
– –
RAVN
297
DELISTED
Raven Industries Inc
RAVN
$379K 0.01%
11,561
+251
+2% +$9.14K
POLY
298
DELISTED
Plantronics, Inc.
POLY
$377K 0.01%
8,479
+339
+4% +$15K
EMC
299
DELISTED
EMC CORPORATION
EMC
$377K 0.01%
13,739
+992
+8% +$25.8K
MEI icon
300
Methode Electronics
MEI
$585M
$376K 0.01%
+12,275
New +$406K
10 11
12
13 14

Similar funds

NIM
NEOS Investment Management Westport, Connecticut $19.8B AUM 31.12% 1-Year Est. Return
HHII
H&H International Investment Palo Alto, California $20B AUM 9.66% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return

Bahl & Gaynor's Q1 2014 Portfolio in Review

As of Q1 2014, Bahl & Gaynor held 404 positions worth $6.24B, up 2.3% from $6.1B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Bahl & Gaynor's Q1 2014 filing shows 21 new, 154 increased, 178 reduced and 12 closed positions. Its largest new stake was Cencora: 276,922 shares worth $18.2M. The largest sale was Intel, an estimated $55.6M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Consumer Staples.

  • Bahl & Gaynor's largest Q1 2014 buy was Cencora: 276,922 shares worth $18.2M.
  • Bahl & Gaynor added most to 3M in Q1 2014, an estimated $83M increase.
  • Bahl & Gaynor's biggest Q1 2014 reduction was Intel, cutting an estimated $55.6M.
  • Bahl & Gaynor fully exited Atrion Corp in Q1 2014, selling an estimated $478K.
  • Bahl & Gaynor's ten largest holdings make up 27% of its $6.24B portfolio in Q1 2014.
  • Bahl & Gaynor opened 21 new positions and closed 12 in Q1 2014.
  • Bahl & Gaynor's portfolio value rose 2.3% quarter-over-quarter to $6.24B.

Based on Bahl & Gaynor's 13F filing for Q1 2014, filed 20 May 2014.